April 1960
New Yorker;4/30/1960, Vol. 36 Issue 11, p116
An excerpt from a press release of the Warner-Lambert Pharmaceutical Co. on methods of population control is presented.


Related Articles

  • National ink.  // Business News New Jersey;10/06/97, Vol. 10 Issue 34, p3 

    Focuses on Lipitor a drug used in fight cholesterol which is distributed by Warner-Lambert. Information on the marketing of the drug; Examination of the therapeutic uses of the drug; Comments from chief executive officer, Melvin R. Goodes.

  • Listerine shapes up with PET barbell.  // Packaging Digest;Aug94, Vol. 31 Issue 9, p1 

    Reports on Warner-Lambert Co.'s repackaging of its Listerine mouthwash using polyethylene terephthalate (PET) bottles. Reasons for the company's decision; Features of the enhanced packaging design; Incorporation of child-resistant (C-R) push-and-turn closures.

  • Warner-Lambert realigns.  // Snack Food;Jan95, Vol. 84 Issue 1, p13 

    Reports on Warner-Lambert's realignment of its consumer healthcare and confectionery sectors due to continued strength and growth. Company's claimed achievement of a critical mass in the pharmaceutical, consumer health and confectionery operations; Establishment of a new confectionery division.

  • Add Parke-Davis. Muirhead, Greg // Drug Topics;11/7/94, Vol. 138 Issue 21, p74 

    Reports on the creation of the Parke-Davis Health Care Systems division at Warner-Lambert Co. to develop disease management programs.

  • Fix it or get out.  // Northern New Jersey Business;4/19/95, Vol. 3 Issue 8, p3 

    Reports that Warner-Lambert is serious about improving the performance of its troubled pharmaceutical business. Plans for new drugs.

  • Hot prospect.  // Northern New Jersey Business;9/6/95, Vol. 3 Issue 18, p3 

    Reports on financial analysts' view on the vulnerability of drug company Warner-Lambert to a takeover. Diversification into non-drug fields as the company's weakness; Talk of a merger between Warner-Lambert and Schering-Plough.

  • Creative downsizing.  // Personnel Journal;Sep92, Vol. 71 Issue 9, Human Resource Supplement p8 

    Examines how Warner Lambert's New Jersey corporate headquarters, as part of a worldwide restructuring effort, eliminated several secretarial and administrative assistant positions. How the company then developed a program that met the economic needs of both the organization and the displaced...

  • W-L Doles $125M to Zantac, resets Rolaids. Mehegan, Sean // Brandweek;4/22/96, Vol. 37 Issue 17, p5 

    Reports on Warner-Lambert's advertising strategy for its Zantac 75 heartburn remedy. Review of brand management for first-generation antacid Rolaids; Amount spent for promotions; Challenges faced by Warner-Lambert.

  • Warner-Lambert agrees to stop production. Segal, Marian // FDA Consumer;Jan/Feb94, Vol. 28 Issue 1, p38 

    Reports that the Warner-Lambert Company agreed in August 1993 to stop making a wide range of drug products until it complied with federal regulations for good manufacturing practices. Terms of the consent decree; List of prescription drugs that remained in production; Discussion of problems...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics